Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: twenty-four-hour versus 7-day infusion.
J Clin Oncol. 1997 Nov;15(11):3399-407. doi: 10.1200/JCO.1997.15.11.3399.
J Clin Oncol. 1997.
PMID: 9363872
Clinical Trial.
A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer.
Vlad AM, Budiu RA, Lenzner DE, Wang Y, Thaller JA, Colonello K, Crowley-Nowick PA, Kelley JL, Price FV, Edwards RP.
Vlad AM, et al. Among authors: colonello k.
Cancer Immunol Immunother. 2010 Feb;59(2):293-301. doi: 10.1007/s00262-009-0750-3.
Cancer Immunol Immunother. 2010.
PMID: 19690855
Free PMC article.
Clinical Trial.
Item in Clipboard
Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix.
Gerszten K, Colonello K, Heron DE, Lalonde RJ, Fitian ID, Comerci JT, Selvaraj RN, Varlotto JM.
Gerszten K, et al. Among authors: colonello k.
Gynecol Oncol. 2006 Aug;102(2):182-8. doi: 10.1016/j.ygyno.2005.12.044. Epub 2006 Mar 3.
Gynecol Oncol. 2006.
PMID: 16516281
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.